Literature DB >> 19830523

Castleman's disease arising from an intrapulmonary lymph node.

Toshiteru Tokunaga1, Yoshihisa Kadota, Tomoki Utsumi, Masayoshi Inoue, Masato Minami, Meinoshin Okumura.   

Abstract

A 23-year-old woman was admitted to our hospital because of an intrapulmonary mass that had been observed for 7 years. Chest computed tomography revealed a 3.5-cm well-defined mass with enhancement in the left lower lobe. During the 7 years of observation, she had been asymptomatic and the tumor size was unchanged. She underwent surgical resection for diagnosis and treatment. Histological examination revealed Castleman's disease of the hyaline vascular type. We present this rare case of solitary Castleman's disease arising from an intrapulmonary lymph node.

Entities:  

Mesh:

Year:  2009        PMID: 19830523     DOI: 10.1007/s11748-009-0434-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  10 in total

1.  CASE records of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 40011.

Authors: 
Journal:  N Engl J Med       Date:  1954-01-07       Impact factor: 91.245

2.  Castleman's disease arising from the chest wall.

Authors:  Makoto Kurai; Ryoichi Kondo; Nobutaka Kobayashi; Akira Hyogotani; Kazuo Yoshida; Jun Amano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-12

3.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

5.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors:  G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

6.  Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.

Authors:  G M Chronowski; C S Ha; R B Wilder; F Cabanillas; J Manning; J D Cox
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

7.  Characteristics of Castleman's disease in Peru.

Authors:  Salim Mohanna; Juvenal Sanchez; Juan Carlos Ferrufino; Francisco Bravo; Eduardo Gotuzzo
Journal:  Eur J Intern Med       Date:  2006-05       Impact factor: 4.487

8.  Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation.

Authors:  H P McAdams; M Rosado-de-Christenson; N F Fishback; P A Templeton
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

9.  Castleman's disease mimicking intrapulmonary malignancy.

Authors:  Chou Ming Yeh; Chia-Man Chou; Lai Ching Wong
Journal:  Ann Thorac Surg       Date:  2007-08       Impact factor: 4.330

10.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

  10 in total
  2 in total

1.  Tumor enucleation for Castleman's disease in the pulmonary hilum: a case report.

Authors:  Masaya Aoki; Go Kamimura; Tadashi Umehara; Aya Harada Takeda; Yui Watanabe; Koki Maeda; Toshiyuki Nagata; Tsunayuki Otsuka; Masami Sato
Journal:  Surg Case Rep       Date:  2019-06-10

2.  Unicentric Castleman's Disease Arising from an Intrapulmonary Lymph Node.

Authors:  Hideki Ota; Hideki Kawai; Tsubasa Matsuo
Journal:  Case Rep Surg       Date:  2013-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.